However, another 2008 report showed that SLCO1B3 overexpression in CRC cells conferred resistance to drug-induced apoptosis, supporting the protumorigenic function of SLCO1B3 [14]. This evidence concerns the gene SLCO1B3 and colorectal carcinoma.